EPISODE · Mar 19, 2024 · 36 MIN
Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?
from Keeping Current CME
Why does it really matter which GnRH agonist or antagonist you choose for your patient, and how can you use the latest data to inform this decision? Credit available for this activity expires: 3/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000411?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?
0:00
36:38
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 36 minutes long.
When was this Keeping Current CME episode published?
This episode was published on March 19, 2024.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!